A historic shift in Canadian drug policy has occurred, as the regulators announce the use of psilocybin hallucinogens for therapeutic purposes. Until now, these substances were severely restricted, but a growing body of evidence suggests they could offer relief for mental health issues like PTSD. This development represents a key step toward recons